Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8561 |
Apcin
|
APC | Cell Cycle/Checkpoint |
Apcin 是后期促进复合物/环体 (APC/C(Cdc20)) E3 连接酶活性的有效竞争性抑制剂,可通过与 Cdc20 结合并阻止底物识别竞争性地抑制 APC/C 依赖性泛素化。它占据 WD40 结构域侧面的 D-box 结合口袋,并可以延长有丝分裂。它通过阻断有丝分裂退出并通过共同添加 Ts-Arg-OMe 协同放大而起作用。 | |||
T16670 |
PS210
|
PDK | PI3K/Akt/mTOR signaling |
PS210 是针对 PDK1的 PIF 结合口袋的、选择性的、有效的 PDK1激活剂,对其他蛋白激酶无活性。在细胞中,它的前药 PS423 可作为 PDK1的底物选择性抑制剂,抑制 S6K 的磷酸化和活化。 | |||
T9627 |
PHD-1-IN-1
|
HIF/HIF Prolyl-Hydroxylase | Chromatin/Epigenetic; Metabolism |
PHD-1-IN-1 是口服有效的缺氧诱导因子脯氨酰羟化酶结构域 1抑制剂,IC50为 0.034 μM。它与活性位 Fe2+具有独特的单齿结合相互作用,并诱导形成一个 “Arg367-out” 口袋。 | |||
T2301 |
SB 202190
FHPI,SB202190 |
Apoptosis; p38 MAPK; Autophagy | Apoptosis; Autophagy; MAPK |
SB 202190 (FHPI) 是一种 p38 MAPK 抑制剂,可以抑制 p38α 和 p38β2 (IC50=50/100 nM),具有选择性和细胞渗透性。SB 202190 具有抗肿瘤活性,还可以诱导人胚胎干细胞向心肌细胞分化。 | |||
T8719 |
SC99
|
Apoptosis; JAK; STAT | Angiogenesis; Apoptosis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
SC99 是一种口服有效选择性STAT3抑制剂,靶向 JAK2-STAT3 途径,抑制血小板活化和聚集,有抗骨髓瘤和抗血栓活性。它结合在 JAK2 的 ATP 结合袋中,抑制 JAK2 和 STAT3 的磷酸化。 | |||
T23969 |
DCAI
|
Others | Others |
DCAI 是一种核苷酸交换和核苷酸释放的抑制剂,通过与 Ras-SOS 界面附近的口袋结合而起作用。 | |||
T15579 |
INDY
1-(3-ethyl-5-hydroxy-1,3-benzothiazol-2-ylidene)propan-2-one |
DYRK | Cell Cycle/Checkpoint; Tyrosine Kinase/Adaptors |
INDY 是 Dyrk1A 和 Dyrk1B 的 ATP 竞争性抑制剂,IC50 分别为 0.24 μM 和 0.23 μM,对 Dyrk1A ATP 口袋的 Ki 为 0.18 μM。 | |||
T10533 |
BI-2852
|
Ras | GPCR/G Protein; MAPK |
BI-2852 是具有纳摩尔亲和力的开关 I/II 口袋(SI/II-口袋)的 KRAS 抑制剂,可抑制 KRAS 突变细胞的下游信号传导和抗增殖作用。 | |||
T1980 |
HA14-1
|
BCL | Apoptosis |
HA14-1 是一种 Bcl-2/Bcl-xL 拮抗剂,与 Bcl-2 上的特定口袋结合,IC50约为 9 μM。 | |||
T9079 |
Apostatin-1
Apt-1 |
Others | Others |
Apostatin-1 (Apt-1) 是一种新型 TRADD 抑制剂。 Apostatin-1 可以与 TRADD 的 N 末端 TRAF2 结合域上的口袋结合。 | |||
T8700 |
TKIM
|
Potassium Channel | Membrane transporter/Ion channel |
TKIM 是一种 TWIK 相关的钾通道 1 (TREK-1) 抑制剂,与 TREK-1 的中间 (IM) 状态的口袋结合。 | |||
T8659 |
K-Ras-PDEδ-IN-1
|
PDE | Metabolism |
K-Ras-PDEδ-IN-1 是新型的 K-Ras-PDEδ 抑制剂,它能够以低纳摩尔Kd8 nM 与 PDEδ 的法尼基结合袋竞争性结合。 | |||
T17205 |
UNC2541
|
Others; FLT; TAM Receptor | Angiogenesis; Others; Tyrosine Kinase/Adaptors |
UNC2541 是 Mer 酪氨酸激酶特异性抑制剂,与 MerTK ATP 结合口袋结合的IC50值为 4.4 nM,对其选择性远高于 Axl,Tyro3 和 Flt3。它能够抑制磷酸化的 MerTK (pMerTK;EC50,510 nM)。 | |||
T3163 |
PS 48
|
PDK | PI3K/Akt/mTOR signaling |
PS 48 已被证明是一种 PKB 激酶 (PDK1) 激活剂 (Kd: 10.3 μM)。该化合物选择性地与 PKB 激酶 (PDK1) 的 PIF 结合口袋结合。 | |||
T10585 |
Bozitinib
CBT-101,PLB-1001 |
c-Met/HGFR | Tyrosine Kinase/Adaptors |
Bozitinib (PLB-1001) 是一种可透过血脑屏障的、高效的、选择性的的、 ATP 竞争性的小分子 c-MET 激酶抑制剂,能够与酪氨酸激酶超家族的常规 ATP 结合口袋结合。 | |||
T35694 |
OD36
OD 36,OD 36 hydrochloride,OD-36 |
ALK; RIP kinase | Angiogenesis; Apoptosis; NF-κB; Tyrosine Kinase/Adaptors |
OD36 是一种选择性强效 RIPK2 抑制剂,IC50 为 5.3 nM。OD36 可抑制 ALK2 信号传导和成骨分化(KD:37 nM),并能与 ALK2 激酶 ATP 袋有效结合。 | |||
T67753 |
Trifluoromethyl-tubercidin
|
Influenza Virus | Microbiology/Virology |
Trifluoromethyl-tubercidin (TFMT)可抑制宿主Mtr1并抑制病毒复制。TFMT 通过其S-adenosyl-l-methionine 结合袋相互作用抑制Mtr1,限制流感病毒复制。TFMT 能有效抑制病毒在小鼠体内的复制,毒性很小。 | |||
T9095 |
Necrostatin-34
2-{[3-cyano-4-(4-methylphenyl)-6-oxo-1,4 |
RIP kinase | Apoptosis; NF-κB |
Necrostatin-34 (2-{[3-cyano-4-(4-methylphenyl)-6-oxo-1,4) 是一种 RIPK1 激酶抑制剂,通过在激酶结构域中占据一个独特的结合口袋,将 RIPK1 激酶稳定在非活性构象中。 | |||
T14978 |
CL-82198
|
MMP | Proteases/Proteasome |
CL-82198 是 MMP-13选择性抑制剂。它能够与 MMP-13 的整个 S1' 口袋结合,这是其对 MMP-13 选择性和对其他 MMP 缺乏抑制活性的基础。它可用于研究骨关节炎。 | |||
T27133 |
DCLX069
DCLX 069,DCLX-069 |
Histone Methyltransferase | Chromatin/Epigenetic |
DCLX069 是一种选择性蛋白精氨酸甲基转移酶 1 抑制剂,IC50值为 17.9 µM,对 PRMT4 和 PRMT6 的活性较低。它可有效阻断乳腺癌、肝癌和急性髓性白血病细胞系中的细胞增殖。 | |||
T9103 |
BVDV-IN-1
|
DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
BVDV-IN-1 是一种牛病毒性腹泻病毒 (BVDV) 的非核苷抑制剂 (NNI),EC50 为 1.8 μM。它直接与 BVDV RdRp 的疏水口袋结合,对耐 NNI 氨基硫脲 (TSC) 的 BVDV 具有抗病毒活性。 | |||
T12609 |
R-10015
|
LIM Kinase; Reverse Transcriptase | Cell Cycle/Checkpoint; Microbiology/Virology |
R-10015 是一种高效选择性 LIMK 抑制剂,通过结合 ATP 结合口袋阻断 LIMK,抑制人 LIMK1 的 IC50值为 38 nM。它还发挥广谱抗病毒作用,可用于 HIV 感染研究。 | |||
T8873 |
Bractoppin
|
Others; DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Others |
Bractoppin 是一种BRCA1 (t)BRCT domain 识别磷酸肽的选择性抑制剂,IC50为 74 nM。它优先抑制 BRCA1 -tBRCT 依赖的 DNA 损伤。它减少 BRCA1 对 DNA 断裂片段的招募,进而抑制损伤诱导的 G2 期阻滞和重组酶 RAD51 的组装。 | |||
T8931L |
ICCB-19 hydrochloride
ICCB-19 HCl(750621-52-4 free base) |
Apoptosis; Others; Autophagy; RIP kinase | Apoptosis; Autophagy; NF-κB; Others |
ICCB-19 hydrochloride (ICCB-19 HCl) 是RIPK1激酶活性的间接抑制剂。它是一种 TRADD 抑制剂,可与 TRADD 的 N 端结构域结合,破坏其与 TRADD-C 和 TRAF2 的结合,诱导自噬和长寿命蛋白质的降解。 | |||
T11807 |
L002
|
Others; Histone Acetyltransferase; STAT | Chromatin/Epigenetic; JAK/STAT signaling; Others; Stem Cells |
L002 是一种细胞可渗透的,可逆特定性乙酰转移酶 p300(KAT3B)抑制剂,IC50为 1.98 μM。 它结合乙酰辅酶 A 口袋并竞争性抑制 FATp300 催化结构域,阻断组蛋白乙酰化和 p53 乙酰化,且抑制 STAT3 激活,有用于高血压引起的心脏肥大和纤维化的研究潜力。 | |||
T29111 |
VPC-13566
|
Androgen Receptor | Endocrinology/Hormones |
VPC-13566 是一种 BF3 特异性小分子,可有效抑制雄激素受体转录活性并从 BF3 口袋中置换出 BAG1L 肽。 VPC-13566 抑制各种前列腺癌细胞系的生长,并减少小鼠中 AR 依赖性前列腺癌异种移植肿瘤的生长。 | |||
T72055 |
FM04
|
P-gp | Membrane transporter/Ion channel; Neuroscience |
FM04 是一种具有口服活性和高效性的 P-糖蛋白 (P-gp) 抑制剂 ,EC50 值为 83 nM。FM04 可以与人P-gp核苷酸结合域2(NBD2)中的Q1193和I1115相互作用。从而破坏 R262-Q1081-Q1118 相互作用口袋并解偶联 ICL2-NBD2 相互作用,从而抑制 P-gp。FM04 可用于癌症和肿瘤的治疗。 | |||
T14322 |
ARP-100
MMP-2 Inhibitor III |
MMP | Proteases/Proteasome |
ARP-100 (MMP-2 Inhibitor III) 是选择性基质金属蛋白酶MMP-2抑制剂 (IC50=12 nM)。它对 MMP-1 (>50 μM),MMP-3 (4.5 μM),MMP-7 (>50 μM) 和MMP-9 (0.2 μM) 的抑制活性较小。它与 MMP-2 的 S1'口袋相互作用,并在体外对基质胶的侵袭模型中显示抗侵袭特性。 | |||
T3157 |
COH29
RNR Inhibitor COH29 |
DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
COH29 (RNR Inhibitor COH29) 是一种口服可用的芳香族取代噻唑,是人类核糖核苷酸还原酶 (RNR) 的抑制剂,具有潜在的抗肿瘤活性。它抑制核糖核苷酸还原酶的IC50为 16 μM。 | |||
T23656 |
VUF11211
VUF-11211,VUF 11211 |
||
VUF11211 is an effective antagonist of CXCR3 that acts by extending from the minor pocket into the major pocket of the transmembrane domains. | |||
T24676 |
PS423
PS210AM,PS 210 AM,PS 423,PS210-AM,PS-423 |
||
PS423 is a substrate-selective protein kinase PDK1 inhibitor that acts by binding to the PIF-pocket allosteric docking site. | |||
T10374 | ARS-1323-alkyne | Ras | GPCR/G Protein; MAPK |
ARS-1323-alkyne 是switch-II pocket (S-IIP)抑制剂,能够特异性报告活体细胞中 KRASG12C 核苷酸的状态。 | |||
T16120 |
MLT-748
|
Others | Others |
MLT-748 is an effective, selective, and allosteric MALT1 inhibitor. It binds MALT1 in the allosteric Trp580 pocket (IC50: 5 nM). | |||
T28458 |
PS432
PS-432,PS 432 |
||
PS432 is an allosteric inhibitor of atypical PKCs. PS432 targets the PIF-pocket resulting in significantly reduce tumor growth without side effects in mouse xenograft model. | |||
T40978 |
Acrylodan
|
||
Acrylodan, when subjected to thiol reactions, exhibits sensitivity to the dipolarity and dynamics of its surrounding binding pocket, specifically those surrounding Cys 34. | |||
T24806 |
SMBA2
SMBA-2,NSC4436,NSC 4436,NSC-4436,SMBA 2 |
||
SMBA2 is a Bax activator. It acts by specifically targeting the binding pocket at S184. | |||
T41113 |
3BrB-PP1
3BrB-PP1 |
||
3BrB-PP1 is an ATP-competitive analog that exhibits specific inhibitory activity towards protein kinase. It is effective in inhibiting protein kinase with mutations in the ATP-binding pocket, specifically the mutation of Thr97 within Sty1's ATP-binding pocket. | |||
T39955 |
JNJ-67569762
|
||
JNJ-67569762 is a selective BACE1 inhibitor targeting the S3 pocket ( IC 50 = 2.7 nM). | |||
T23901 |
CM026
CM 026,CM-026 |
||
CM026 is a selective aldehyde dehydrogenase 1A1 inhibitor that acts by binding within the aldehyde binding pocket of ALDH1A1 in an uncompetitive partial mode of inhibition. | |||
T10446 |
BA-53038B
|
Others | Others |
BA-53038B is an HBV core protein allosteric modulator (CpAM), binding to the HAP pocket and modulating HBV capsid assembly in a distinct manner (EC50: 3.32 μM). | |||
T68466 |
BI-207524
|
||
BI-207524 is a novel NS5B Thumb Pocket 1 Inhibitor with Improved Potency for the Potential Treatment of Chronic Hepatitis C Virus Infection. | |||
T39440 |
CXCL12 ligand 1
|
||
CXCL12 ligand 1 is the first ligand of the sY12-binding pocket on chemokine CXCL12 . | |||
T26343 |
YK5
YK 5,YK-5 |
||
YK5 is an allosteric inhibitor pocket of Hsp70 and represents a previously unknown chemical tool to investigate cellular mechanisms associated with Hsp70. | |||
T16119 |
MLT-747
|
Others | Others |
MLT-747 is an effective and allosteric inhibitor of MALT1. It binds MALT1 in the allosteric Trp580 pocket (IC50: 14 nM). | |||
T71939 |
PS77
|
||
PS77 is a Pkh inhibitor directed to the PIF-pocket with increased selectivity for C. albicans Pkh2. | |||
T28389 |
PF-6422899
PF6422899,PF 6422899 |
||
PF-6422899 irreversibly inhibits EGFR kinase activity by binding covalently to active-site cysteine residues in the ATP binding pocket of EGFR. | |||
T24098 |
GP17
GP-17,GP 17 |
||
GP17 is a type II kinase inhibitor of the IRE1α endoribonuclease that acts by targeting the ATP-binding pocket of IRE1α. | |||
T24099 |
GP29
GP-29,GP 29 |
||
GP29 is a Type II kinase inhibitor of the IRE1α endoribonuclease that acts by targeting the ATP-binding pocket of IRE1α. | |||
T32500 |
L6Y
TTR stabilizer L6 |
||
L6Y is a transthyretin (TTR) stabilizer which binds to the T4 binding pocket of TTR and prevents the dissociation of TTR to monomer. | |||
T71843 |
HPA-12
|
||
HPA-12 is a novel potent inhibitor of cert, binding to the ceramide-binding pocket in the cert start domain |